KCI Files for $100 Million IPO

April 18, 2019

On 4/17/19 KCI Holdings filed for a $100 million IPO. KCI is a leading medical technology company focused on advanced wound care and specialty surgical applications. The initial filing did not specify the number of shares to be offered or the symbol the company intends to trade under.

KCI introduced its ground breaking negative pressure wound therapy (NPWT) over 20 years ago. For the year ended December  31, 2018, its NPWT product line generated $1.152 billion of revenue, representing 78.5% of our total revenue and 4.5% growth compared to 2017. The company also has offerings in the specialty surgical market and the advanced wound dressings market.


CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.